Predictors of Drug Resistant Epilepsy Among Pediatric Patients

Sponsor
Assiut University
Study ID
NCT07241754
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
1 Year - 18 Years
Healthy Volunteers
Not accepted

Study Details

1. This study aims to determine the main predictors of drug resistance in pediatric epilepsy by examining clinical data, EEG abnormalities, and neuroimaging results, in order to support early identification of resistant cases and improve treatment strategies . 2. Early introduction of new lines of treatment in case of refractory epilepsy as : Ketogenic diet , Rituximab and solumedrol

Key Dates

First listed
Nov 21, 2025
Start date
Dec 29, 2025
Status verified
Oct 2025
Primary completion
Dec 29, 2026
Completion
Feb 1, 2027

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Predictors of Drug Resistance in Pediatric Epilepsy [ Time Frame: through 12 months of follow-up. ]

Central Contacts

Find similar trials

Nationwide
Epilepsy trialsNeurology trialsBrain disorders trials

Related Studies